These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 21194623)

  • 1. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.
    Santini C; Pellei M; Papini G; Morresi B; Galassi R; Ricci S; Tisato F; Porchia M; Rigobello MP; Gandin V; Marzano C
    J Inorg Biochem; 2011 Feb; 105(2):232-40. PubMed ID: 21194623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
    Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
    Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.
    Gandin V; Tisato F; Dolmella A; Pellei M; Santini C; Giorgetti M; Marzano C; Porchia M
    J Med Chem; 2014 Jun; 57(11):4745-60. PubMed ID: 24793739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.
    Liu JJ; Galettis P; Farr A; Maharaj L; Samarasinha H; McGechan AC; Baguley BC; Bowen RJ; Berners-Price SJ; McKeage MJ
    J Inorg Biochem; 2008 Feb; 102(2):303-10. PubMed ID: 18029019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
    J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
    J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel metalloantimalarials: Transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei.
    Tapanelli S; Habluetzel A; Pellei M; Marchiò L; Tombesi A; Capparè A; Santini C
    J Inorg Biochem; 2017 Jan; 166():1-4. PubMed ID: 27815977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
    Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
    J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
    Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
    Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
    Marzano C; Gandin V; Pellei M; Colavito D; Papini G; Lobbia GG; Del Giudice E; Porchia M; Tisato F; Santini C
    J Med Chem; 2008 Feb; 51(4):798-808. PubMed ID: 18251492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
    Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
    J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.
    Vergara E; Casini A; Sorrentino F; Zava O; Cerrada E; Rigobello MP; Bindoli A; Laguna M; Dyson PJ
    ChemMedChem; 2010 Jan; 5(1):96-102. PubMed ID: 19937669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly luminescent gold(I)-silver(I) and gold(I)-copper(I) chalcogenide clusters.
    Crespo O; Gimeno MC; Laguna A; Larraz C; Villacampa MD
    Chemistry; 2007; 13(1):235-46. PubMed ID: 17009375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior cytotoxicity of hydrophylic gold carboxylato complexes over hydrophylic silver carboxylates.
    Langner EH; Swarts JC; Tuchscherer A; Lang H; Joone GK; VAN Rensburg CE
    Anticancer Res; 2012 Jul; 32(7):2697-701. PubMed ID: 22753728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
    Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
    Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
    J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.